Improved arterial compliance by a novel advanced glycation end-product crosslink breaker

Circulation

Volumn 104, Issue 13, 2001, Pages 1464-1470

  Kass, D A ^a   Shapiro, E P ^a   Kawaguchi, M ^a   Capriotti, A R ^a   Scuteri, A ^a   DeGroof, R C ^a   Lakatta, E G ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Aging; ALT 711; Arteries; Compliance; Glycosylation end products, advanced; Hypertension

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ALAGEBRIUM; ANTIHYPERTENSIVE AGENT; PLACEBO; THIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTERY COMPLIANCE; ARTICLE; ASTHENIA; BIOMECHANICS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG MECHANISM; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; RASH; SYSTOLIC BLOOD PRESSURE; VERTIGO;

EID: 0035949502     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/hc3801.097806     Document Type: Article

References (39)

1. Aging
2. Age-related abnormalities in arterial compliance identified by pressure pulse contour analysis: Aging and arterial compliance
3. Arterial stiffness, hypertension and diabetes mellitus
4. Impact of arterial stiffening on left ventricular structure
5. Pulse pressure: A review of mechanisms and clinical relevance
6. Pulse pressure and aortic pulse wave are markers of cardiovascular risk in hypertensive populations
7. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham heart study
8. Increased pulse pressure and risk of heart failure in the elderly
9. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients
10. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham heart study
11. Pulse pressure and mortality in older people
12. Pulse pressure and risk for myocardial infarction and heart failure in the elderly
13. Epidemiological findings imply that goals for drug treatment of hypertension need to be revised
14. Therapeutic studies and arterial stiffness in hypertension: Recommendations of the European Society of Hypertension: The Clinical Committee of Arterial Structure and Function, Working Group on Vascular Structure and Function of the European Society of Hypertension
15. Is there a preferred antihypertensive therapy for isolated systolic hypertension and reduced arterial compliance?
16. Antihypertensive treatment and the J-curve
17. Drug treatment of hypertension: The reduction of pulse pressure does not necessarily parallel that of systolic and diagnostic blood pressure
18. Role of glycation in aging
19. Diminisbed arterial elasticity in diabetes: Association with fluorescent advanced glycosylation end products in collagen
20. Breakers of advanced glycation end products restore large artery properties in experimental diabetes
21. Aminoguanidine prevents age-related stiffening and cardiac hypertrophy
22. An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness
23. A cross-link breaker has sustained effects on arterial and ventricular properties in older rhesus monkeys
24. An agent cleaving glucose-derived protein crosslinks in vitro and in vivo
25. Estimation of central aortic pressure waveform by mathematical transformation of radial tonometry pressure: Validation of generalized transfer function
26. Parametric model derivation of transfer function for non-invasive estimation of aortic pressure by radial tonometry
27. Contours of pressure and flow waves in arteries
28. Aortic compliance in human hypertension
29. Total arterial compliance estimated by stroke volume- to-aortic pulse pressure ratio in humans
30. The pulse pressure-to-stroke index ratio predicts cardiovascular events and death in uncomplicated hypertension
31. The placebo effect and white coat effect in isolated systolic hypertension and systo-diastolic hypertension
32. Random zero sphygomomanometer versus automatic oscillometric blood pressure monitor; is either the instrument of choice?
33. Arterial stiffness as underlying mechanism of disagreement between an oscillometric blood pressure monitor anda sphygmomanometer
34. Use of pulse pressure method for estimating total arterial compliance
35. Effect of reduced aortic compliance on cardiac efficiency and contractile function of in situ canine left ventricle
36. Antihypertensive effect of sustained-release isosorbide dinitrate for isolated systolic systemic hypertension in the elderly
37. Baroreflex sensitivity changes with calcium antagonist therapy in elderly subjects with isolated systolic hypertension
38. Influence of captopril, propranolol, and verapamil on arterial pulse wave velocity and other cardiovascular parameters in healthy volunteers
39. Aging, habitual exercise, and dynamic arterial compliance